Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of ryanodine-sensitive calcium-release channel activity

JPH1 JPH4 JPH3

3.15e-0526493GO:0060314
GeneOntologyBiologicalProcessregulation of COPII vesicle coating

MAPK15 SAR1B

5.50e-055492GO:0003400
GeneOntologyCellularComponentjunctional membrane complex

JPH1 JPH4 JPH3

1.07e-069503GO:0030314
GeneOntologyCellularComponentjunctional sarcoplasmic reticulum membrane

JPH1 JPH4 JPH3

1.53e-0610503GO:0014701
GeneOntologyCellularComponentNURF complex

RBBP4 RBBP7

1.17e-047502GO:0016589
GeneOntologyCellularComponentsarcoplasmic reticulum membrane

JPH1 JPH4 JPH3

1.70e-0445503GO:0033017
GeneOntologyCellularComponentISWI-type complex

RBBP4 RBBP7

5.01e-0414502GO:0031010
GeneOntologyCellularComponentCHD-type complex

RBBP4 RBBP7

7.45e-0417502GO:0090545
GeneOntologyCellularComponentESC/E(Z) complex

RBBP4 RBBP7

7.45e-0417502GO:0035098
GeneOntologyCellularComponentNuRD complex

RBBP4 RBBP7

7.45e-0417502GO:0016581
GeneOntologyCellularComponentsarcoplasmic reticulum

JPH1 JPH4 JPH3

1.22e-0388503GO:0016529
GeneOntologyCellularComponentSin3-type complex

RBBP4 RBBP7

1.26e-0322502GO:0070822
GeneOntologyCellularComponentsarcoplasm

JPH1 JPH4 JPH3

2.57e-03114503GO:0016528
DomainJunctophilin

JPH1 JPH4 JPH3

6.36e-084483IPR017191
DomainMORN

JPH1 JPH4 JPH3

5.68e-0614483SM00698
DomainMORN

JPH1 JPH4 JPH3

7.09e-0615483IPR003409
DomainMORN

JPH1 JPH4 JPH3

7.09e-0615483PF02493
DomainCAF1C_H4-bd

RBBP4 RBBP7

1.94e-053482PF12265
DomainHistone-bd_RBBP4_N

RBBP4 RBBP7

1.94e-053482IPR022052
DomainNa/ntran_symport_orphan

SLC6A17 SLC6A15

6.44e-055482IPR002438
Domain14_3_3

YWHAQ SFN

1.35e-047482SM00101
Domain1433_1

YWHAQ SFN

1.35e-047482PS00796
Domain1433_2

YWHAQ SFN

1.35e-047482PS00797
Domain14-3-3_domain

YWHAQ SFN

1.35e-047482IPR023410
Domain14-3-3_CS

YWHAQ SFN

1.35e-047482IPR023409
Domain14-3-3

YWHAQ SFN

1.35e-047482PF00244
Domain14-3-3

YWHAQ SFN

1.79e-048482IPR000308
DomainTGc

KY TGM6

3.51e-0411482SM00460
DomainTransglut_core

KY TGM6

3.51e-0411482PF01841
DomainTransglutaminase-like

KY TGM6

3.51e-0411482IPR002931
Domain6-hairpin_glycosidase-like

PHKB LANCL2

4.95e-0413482IPR008928
DomainNA_NEUROTRAN_SYMP_2

SLC6A17 SLC6A15

9.64e-0418482PS00754
DomainSNF

SLC6A17 SLC6A15

1.08e-0319482PF00209
DomainNA_NEUROTRAN_SYMP_1

SLC6A17 SLC6A15

1.08e-0319482PS00610
DomainNA_NEUROTRAN_SYMP_3

SLC6A17 SLC6A15

1.08e-0319482PS50267
DomainNa/ntran_symport

SLC6A17 SLC6A15

1.08e-0319482IPR000175
DomainG-protein_beta_WD-40_rep

RBBP4 RBBP7 BTRC

1.36e-0385483IPR020472
DomainGlycos_transf_2

B3GNTL1 GALNT7

2.69e-0330482PF00535
DomainGlyco_trans_2-like

B3GNTL1 GALNT7

2.69e-0330482IPR001173
DomainArf

SAR1B ARL13B

2.87e-0331482PF00025
DomainSmall_GTPase_ARF/SAR

SAR1B ARL13B

3.25e-0333482IPR006689
DomainWD40

RBBP4 RBBP7 EML2 BTRC

4.36e-03259484PF00400
DomainWD40

RBBP4 RBBP7 EML2 BTRC

4.92e-03268484SM00320
DomainWD40_repeat

RBBP4 RBBP7 EML2 BTRC

5.18e-03272484IPR001680
DomainABC_transporter_CS

ABCA4 ABCF3

5.22e-0342482IPR017871
DomainWD_REPEATS_1

RBBP4 RBBP7 EML2 BTRC

5.59e-03278484PS00678
DomainWD_REPEATS_2

RBBP4 RBBP7 EML2 BTRC

5.66e-03279484PS50082
DomainWD_REPEATS_REGION

RBBP4 RBBP7 EML2 BTRC

5.66e-03279484PS50294
DomainCyt_P450_E_grp-I

CYP2B6 CYP2C19

5.97e-0345482IPR002401
DomainABC_tran

ABCA4 ABCF3

6.77e-0348482PF00005
DomainABC_TRANSPORTER_2

ABCA4 ABCF3

6.77e-0348482PS50893
DomainWD40_repeat_dom

RBBP4 RBBP7 EML2 BTRC

7.04e-03297484IPR017986
DomainABC_TRANSPORTER_1

ABCA4 ABCF3

7.04e-0349482PS00211
DomainABC_transporter-like

ABCA4 ABCF3

7.32e-0350482IPR003439
PathwayBIOCARTA_PRC2_PATHWAY

RBBP4 RBBP7

3.25e-0411352MM1548
PathwayREACTOME_CYP2E1_REACTIONS

CYP2B6 CYP2C19

3.25e-0411352M27130
PathwayREACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS

YWHAQ SFN

3.89e-0412352M45022
PathwayREACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS

YWHAQ SFN

3.89e-0412352MM15657
PathwayREACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX

YWHAQ SFN

3.89e-0412352MM15443
PathwayREACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA

YWHAQ SFN

3.89e-0412352MM14482
PathwayREACTOME_CYP2E1_REACTIONS

CYP2B6 CYP2C19

3.89e-0412352MM14847
PathwayREACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS

YWHAQ SFN

3.89e-0412352M27939
PathwayREACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX

YWHAQ SFN

4.59e-0413352M27708
PathwayBIOCARTA_PRC2_PATHWAY

RBBP4 RBBP7

5.35e-0414352M22025
PathwayREACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA

YWHAQ SFN

6.16e-0415352M26902
PathwayWP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2

RBBP4 RBBP7

7.03e-0416352M39484
PathwayREACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS

YWHAQ SFN

7.03e-0416352M46428
PathwayREACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS

YWHAQ SFN

8.94e-0418352MM14510
PathwayREACTOME_SARS_COV_INFECTIONS

RBBP4 RBBP7 SAR1B SRPK2 YWHAQ SFN

9.59e-04471356M39009
PathwayWP_NUCLEAR_RECEPTORS_METAPATHWAY

CYP2B6 CYP2C19 SLC6A17 SLC6A15 FGF13

9.96e-04314355M39428
PathwayREACTOME_INFECTIOUS_DISEASE

PSMD6 RHBDF2 RBBP4 RBBP7 SAR1B SRPK2 YWHAQ BTRC SFN

1.01e-031081359M27548
PathwayPID_P38_MK2_PATHWAY

YWHAQ SFN

1.22e-0321352M199
PathwayREACTOME_VIRAL_INFECTION_PATHWAYS

PSMD6 RBBP4 RBBP7 SAR1B SRPK2 YWHAQ BTRC SFN

1.23e-03888358M48034
PathwayREACTOME_FOXO_MEDIATED_TRANSCRIPTION

YWHAQ SFN

1.34e-0322352MM15656
PathwayKEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119

RBBP4 RBBP7

1.34e-0322352M47924
PathwayREACTOME_XENOBIOTICS

CYP2B6 CYP2C19

1.47e-0323352M5372
PathwayREACTOME_RHO_GTPASES_ACTIVATE_PKNS

YWHAQ SFN

1.47e-0323352MM15216
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6

RBBP4 RBBP7

1.73e-0325352MM15546
PathwayREACTOME_XENOBIOTICS

CYP2B6 CYP2C19

1.73e-0325352MM14846
PathwayREACTOME_PTEN_REGULATION

PSMD6 RBBP4 RBBP7

1.81e-0398353MM15348
PathwayPID_INSULIN_GLUCOSE_PATHWAY

YWHAQ SFN

1.87e-0326352M247
PathwayREACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION

RBBP4 RBBP7

2.02e-0327352MM15537
PathwayKEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES

RBBP4 RBBP7

2.02e-0327352M47941
Pubmed

Coexpression of junctophilin type 3 and type 4 in brain.

JPH1 JPH4 JPH3

2.97e-09351314559359
Pubmed

Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity.

JPH1 JPH4 JPH3

1.19e-08451317347645
Pubmed

BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma.

RBBP7 YWHAQ SFN

6.47e-071251329686263
Pubmed

New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.

JPH1 JPH4 JPH3

6.47e-071251319095005
Pubmed

Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47.

RBBP4 RBBP7 YWHAQ LANCL2 SFN

9.69e-0712151522354994
Pubmed

Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism.

CYP2B6 CYP2C19

2.11e-06251222281205
Pubmed

Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus.

CYP2B6 CYP2C19

2.11e-06251217407229
Pubmed

Functional uncoupling between Ca2+ release and afterhyperpolarization in mutant hippocampal neurons lacking junctophilins.

JPH4 JPH3

2.11e-06251216809425
Pubmed

Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.

CYP2B6 CYP2C19

2.11e-06251221108329
Pubmed

Characterization of the gene encoding mouse retinoblastoma binding protein-7, a component of chromatin-remodeling complexes.

RBBP4 RBBP7

2.11e-06251212376095
Pubmed

Metabolism of (-)-cis- and (-)-trans-rose oxide by cytochrome P450 enzymes in human liver microsomes.

CYP2B6 CYP2C19

2.11e-06251226126958
Pubmed

Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport.

SLC6A17 SLC6A15

2.11e-06251219147495
Pubmed

Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.

CYP2B6 CYP2C19

2.11e-06251226456622
Pubmed

Interpreting the molecular mechanisms of RBBP4/7 and their roles in human diseases (Review).

RBBP4 RBBP7

2.11e-06251238577935
Pubmed

Overlapping functions of RBBP4 and RBBP7 in regulating cell proliferation and histone H3.3 deposition during mouse preimplantation development.

RBBP4 RBBP7

2.11e-06251234709113
Pubmed

Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans.

CYP2B6 CYP2C19

2.11e-06251215284537
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

PRSS3P2 SMG1 RBBP4 RBBP7 SIPA1L1 SAR1B SRPK2 YWHAQ

3.39e-0662651833644029
Pubmed

Analysis of phosphorylation-dependent protein-protein interactions of histone h3.

RBBP4 RBBP7 YWHAQ

3.88e-062151325330109
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

PSMD6 SMG1 PHKB MAPK15 RBBP4 RBBP7 YWHAQ BTRC SFN

6.27e-0691051936736316
Pubmed

The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor alpha mediated gene expression.

RBBP4 RBBP7

6.32e-06351218577416
Pubmed

Characterization of human junctophilin subtype genes.

JPH1 JPH3

6.32e-06351210891348
Pubmed

Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437.

YWHAQ SFN

6.32e-06351212816952
Pubmed

Junctophilins: a novel family of junctional membrane complex proteins.

JPH1 JPH3

6.32e-06351210949023
Pubmed

Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

CYP2B6 CYP2C19

6.32e-06351223834474
Pubmed

Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast.

RBBP4 RBBP7

6.32e-0635127503932
Pubmed

Abnormal features in mutant cerebellar Purkinje cells lacking junctophilins.

JPH4 JPH3

6.32e-06351217904530
Pubmed

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

CYP2B6 CYP2C19

6.32e-06351216183265
Pubmed

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.

CYP2B6 CYP2C19

6.32e-06351216338275
Pubmed

Junctophilins 1, 2, and 3 all support voltage-induced Ca2+ release despite considerable divergence.

JPH1 JPH3

6.32e-06351235089322
Pubmed

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects.

CYP2B6 CYP2C19

6.32e-06351228117133
Pubmed

Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects.

CYP2B6 CYP2C19

6.32e-06351219693007
Pubmed

The MTA1 subunit of the nucleosome remodeling and deacetylase complex can recruit two copies of RBBP4/7.

RBBP4 RBBP7

6.32e-06351227144666
Pubmed

DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.

RBBP4 RBBP7 BTRC

9.48e-062851317079684
Pubmed

Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients.

CYP2B6 CYP2C19

1.26e-05451221741706
Pubmed

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.

CYP2B6 CYP2C19

1.26e-05451215248218
Pubmed

Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB.

RBBP4 RBBP7

1.26e-05451210866654
Pubmed

Isolation of human NURF: a regulator of Engrailed gene expression.

RBBP4 RBBP7

1.26e-05451214609955
Pubmed

Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway.

YWHAQ SFN

1.26e-0545128515476
Pubmed

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects.

CYP2B6 CYP2C19

1.26e-05451216772608
Pubmed

Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.

RBBP4 RBBP7

1.26e-05451224727455
Pubmed

Mrg15 stimulates Ash1 H3K36 methyltransferase activity and facilitates Ash1 Trithorax group protein function in Drosophila.

RBBP4 RBBP7

2.10e-05551229158494
Pubmed

Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study.

CYP2B6 CYP2C19

2.10e-05551219926050
Pubmed

Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

YWHAQ SFN

2.10e-05551215367659
Pubmed

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.

CYP2B6 CYP2C19

2.10e-05551219414633
Pubmed

MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.

RBBP4 RBBP7

2.10e-05551210471499
Pubmed

Junctophilin Proteins Tether a Cav1-RyR2-KCa3.1 Tripartite Complex to Regulate Neuronal Excitability.

JPH4 JPH3

2.10e-05551231461656
Pubmed

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

CYP2B6 CYP2C19

2.10e-05551218024866
Pubmed

Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19.

CYP2B6 CYP2C19

2.10e-05551216116487
Pubmed

Stratifin Inhibits SCFFBW7 Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis.

BTRC SFN

2.10e-05551230728155
Pubmed

Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.

CYP2B6 CYP2C19

2.10e-05551217047492
Pubmed

Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.

CYP2B6 CYP2C19

2.10e-05551219029318
Pubmed

Cytochrome p-450 polymorphisms and response to clopidogrel.

CYP2B6 CYP2C19

2.10e-05551219106084
Pubmed

Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

CYP2B6 CYP2C19

2.10e-05551216267764
Pubmed

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.

CYP2B6 CYP2C19

3.15e-05651217900275
Pubmed

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.

CYP2B6 CYP2C19

3.15e-05651220179710
Pubmed

14-3-3 isoforms are induced by aldosterone and participate in its regulation of epithelial sodium channels.

YWHAQ SFN

3.15e-05651216613846
Pubmed

Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons.

SRPK2 YWHAQ

3.15e-05651219592491
Pubmed

Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol.

CYP2B6 CYP2C19

3.15e-0565128043019
Pubmed

SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex.

RBBP4 RBBP7

3.15e-05651216738318
Pubmed

14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport.

YWHAQ SFN

3.15e-05651211864996
Pubmed

Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase.

RBBP4 RBBP7

3.15e-0565129427644
Pubmed

CRL4(RBBP7) is required for efficient CENP-A deposition at centromeres.

RBBP4 RBBP7

3.15e-05651225795299
Pubmed

Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases.

RBBP4 RBBP7

3.15e-05651211788710
Pubmed

The structure of the core NuRD repression complex provides insights into its interaction with chromatin.

RBBP4 RBBP7

3.15e-05651227098840
Pubmed

Expression, purification and characterization of the human MTA2-RBBP7 complex.

RBBP4 RBBP7

3.15e-05651228179136
Pubmed

BRCA1 interacts with components of the histone deacetylase complex.

RBBP4 RBBP7

3.15e-05651210220405
Pubmed

Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex.

RBBP4 RBBP7

4.41e-05751219686092
Pubmed

Smad-dependent recruitment of a histone deacetylase/Sin3A complex modulates the bone morphogenetic protein-dependent transcriptional repressor activity of Nkx3.2.

RBBP4 RBBP7

4.41e-05751214612411
Pubmed

Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins.

YWHAQ SFN

4.41e-05751215023544
Pubmed

The expression of seven 14-3-3 isoforms in human meningioma.

YWHAQ SFN

4.41e-05751220388496
Pubmed

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

CYP2B6 CYP2C19

4.41e-05751218979093
Pubmed

cAMP-elevation mediated by β-adrenergic stimulation inhibits salt-inducible kinase (SIK) 3 activity in adipocytes.

YWHAQ SFN

4.41e-05751222588126
Pubmed

A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo.

YWHAQ SFN

4.41e-05751212383250
Pubmed

Differential Subcellular Distribution and Translocation of Seven 14-3-3 Isoforms in Response to EGF and During the Cell Cycle.

YWHAQ SFN

4.41e-05751231906564
Pubmed

CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex.

RBBP4 RBBP7

4.41e-05751220523938
Pubmed

SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner.

YWHAQ SFN

4.41e-05751219640509
Pubmed

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

RBBP4 RBBP7

4.41e-05751212435631
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

PHKB B3GNTL1 RHBDF2 RBBP4 SPSB1 TMC6 SRPK2 FGF13 GALNT7 SH3RF3

5.15e-051489511028611215
Pubmed

Identification and characterization of human FNBP3 gene in silico.

CYP2B6 CYP2C19

5.87e-05851212964049
Pubmed

Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex.

RBBP4 RBBP7

5.87e-05851218182442
Pubmed

Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex.

RBBP4 RBBP7

5.87e-05851211118440
Pubmed

Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.

RBBP4 RBBP7

5.87e-05851210471500
Pubmed

BCR kinase phosphorylates 14-3-3 Tau on residue 233.

YWHAQ SFN

5.87e-05851216045749
Pubmed

Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.

CYP2B6 CYP2C19

5.87e-05851217502835
Pubmed

The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex.

RBBP4 RBBP7

5.87e-05851218067919
Pubmed

RSG1 is required for cilia-dependent neural tube closure.

ARL13B LHX3

5.87e-05851238721990
Pubmed

ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.

CYP2B6 CYP2C19

5.87e-05851219593168
Pubmed

Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation.

RBBP4 RBBP7

5.87e-05851220144788
Pubmed

The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes.

RBBP4 RBBP7

5.87e-05851211297506
Pubmed

MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.

RBBP4 RBBP7

5.87e-05851212705869
Pubmed

The Fuzzy planar cell polarity protein (FUZ), necessary for primary cilium formation, is essential for pituitary development.

ARL13B LHX3

5.87e-05851237794731
Pubmed

Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.

CYP2B6 CYP2C19

5.87e-05851218356043
Pubmed

Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation.

YWHAQ SFN

5.87e-05851218332103
Pubmed

Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.

CYP2B6 CYP2C19

5.87e-05851218854779
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

PHKB RBBP4 SIPA1L1 YWHAQ BTRC SFN

6.73e-0547551631040226
Pubmed

Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity.

RBBP4 RBBP7

7.54e-05951223104054
Pubmed

Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.

YWHAQ SFN

7.54e-05951216511560
Pubmed

Identification of a nuclear domain with deacetylase activity.

RBBP4 RBBP7

7.54e-05951210984530
Pubmed

JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.

RBBP4 RBBP7

7.54e-05951220075857
Pubmed

MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.

YWHAQ SFN

7.54e-05951216888623
InteractionGNGT2 interactions

SRPK2 YWHAQ SFN

3.11e-0612503int:GNGT2
InteractionNKX3-2 interactions

RBBP4 RBBP7 BTRC

4.04e-0613503int:NKX3-2
InteractionTJP2 interactions

JPH4 SIPA1L1 ARL13B SRPK2 YWHAQ SFN JPH3

6.68e-06288507int:TJP2
InteractionRALGPS2 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

9.67e-0654504int:RALGPS2
InteractionMAST2 interactions

SRPK2 YWHAQ BTRC SFN

1.29e-0558504int:MAST2
InteractionZHX2 interactions

RBBP4 RBBP7 LHX3 YWHAQ

2.57e-0569504int:ZHX2
InteractionNADK interactions

SIPA1L1 SRPK2 YWHAQ SFN

4.61e-0580504int:NADK
InteractionCLASRP interactions

JPH4 ABCF3 RBBP4 SRPK2

4.61e-0580504int:CLASRP
InteractionTANC2 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

7.01e-0589504int:TANC2
InteractionDYNC1I2 interactions

PSMD6 PHKB RBBP4 RBBP7 YWHAQ PPID

8.65e-05295506int:DYNC1I2
InteractionEPB41L5 interactions

RHBDF2 ARL13B FGF13 YWHAQ LANCL2 SFN

9.14e-05298506int:EPB41L5
InteractionSAP18 interactions

PHKB ABCF3 RBBP4 RBBP7 BTRC SFN

1.04e-04305506int:SAP18
InteractionH3C10 interactions

MMS22L RBBP4 RBBP7

1.14e-0438503int:H3C10
InteractionDENND1A interactions

SIPA1L1 YWHAQ SH3RF3 SFN

1.15e-04101504int:DENND1A
InteractionING1 interactions

RBBP4 RBBP7 YWHAQ SFN

1.24e-04103504int:ING1
InteractionPTPN13 interactions

SIPA1L1 ARL13B YWHAQ SH3RF3 SFN

1.41e-04202505int:PTPN13
InteractionOSBPL3 interactions

JPH4 FGF13 YWHAQ SFN

1.59e-04110504int:OSBPL3
InteractionH3C12 interactions

MMS22L RBBP4 RBBP7

1.65e-0443503int:H3C12
InteractionKCNK15 interactions

YWHAQ SFN

1.67e-048502int:KCNK15
InteractionTNFAIP8L2 interactions

SRPK2 BTRC

1.67e-048502int:TNFAIP8L2
InteractionFAM171A2 interactions

JPH4 ARL13B YWHAQ SFN

1.71e-04112504int:FAM171A2
InteractionMPRIP interactions

JPH4 YWHAQ BTRC SFN JPH3

1.85e-04214505int:MPRIP
InteractionTFE3 interactions

RBBP4 RBBP7 YWHAQ PPID BTRC SFN

2.00e-04344506int:TFE3
InteractionSIPA1L3 interactions

SIPA1L1 SRPK2 YWHAQ SFN

2.09e-04118504int:SIPA1L3
InteractionKCNK9 interactions

YWHAQ SFN

2.15e-049502int:KCNK9
InteractionRAI14 interactions

RHBDF2 ARL13B YWHAQ BTRC JPH3

2.29e-04224505int:RAI14
InteractionLUC7L2 interactions

RBBP4 RBBP7 SRPK2 YWHAQ BTRC SFN

2.30e-04353506int:LUC7L2
InteractionPHLDB1 interactions

SRPK2 YWHAQ SFN

2.44e-0449503int:PHLDB1
InteractionPPM1H interactions

SIPA1L1 SLC6A15 YWHAQ SH3RF3

2.45e-04123504int:PPM1H
InteractionAEBP2 interactions

RBBP4 RBBP7 BTRC

2.59e-0450503int:AEBP2
InteractionPLEKHA5 interactions

RHBDF2 SIPA1L1 SRPK2 YWHAQ SFN

2.64e-04231505int:PLEKHA5
InteractionRAP1GAP interactions

YWHAQ BTRC SFN

2.75e-0451503int:RAP1GAP
InteractionSH3PXD2A interactions

SIPA1L1 YWHAQ SH3RF3 SFN

2.85e-04128504int:SH3PXD2A
InteractionUSP43 interactions

RBBP4 RBBP7 YWHAQ

2.92e-0452503int:USP43
InteractionSH3BP4 interactions

SIPA1L1 ARL13B YWHAQ SFN

3.03e-04130504int:SH3BP4
InteractionFRMD6 interactions

ARL13B YWHAQ SFN

3.08e-0453503int:FRMD6
InteractionACACB interactions

RBBP4 RBBP7 SAR1B BTRC

3.12e-04131504int:ACACB
InteractionKSR1 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

3.21e-04132504int:KSR1
InteractionH4C2 interactions

MMS22L RBBP4 RBBP7

3.26e-0454503int:H4C2
InteractionCDCA7 interactions

YWHAQ SFN

3.27e-0411502int:CDCA7
InteractionADPRH interactions

SPSB1 SRPK2

3.27e-0411502int:ADPRH
InteractionCDC25B interactions

SIPA1L1 YWHAQ BTRC SFN

3.40e-04134504int:CDC25B
InteractionSPANXN4 interactions

RBBP4 RBBP7 LANCL2

3.44e-0455503int:SPANXN4
InteractionPPP1R3E interactions

YWHAQ SFN

3.92e-0412502int:PPP1R3E
InteractionPDE7B interactions

SRPK2 YWHAQ

3.92e-0412502int:PDE7B
InteractionDENND4C interactions

SIPA1L1 YWHAQ SH3RF3 SFN

4.01e-04140504int:DENND4C
InteractionFN3KRP interactions

RBBP4 RBBP7 BTRC

4.03e-0458503int:FN3KRP
InteractionRYR2 interactions

JPH4 SAR1B JPH3

4.03e-0458503int:RYR2
InteractionH4C13 interactions

MMS22L RBBP4 RBBP7

4.03e-0458503int:H4C13
InteractionFRYL interactions

CCDC187 YWHAQ SFN

4.03e-0458503int:FRYL
InteractionPPP1R12C interactions

JPH4 YWHAQ SFN

4.03e-0458503int:PPP1R12C
InteractionKIF13B interactions

SIPA1L1 YWHAQ SH3RF3 SFN

4.23e-04142504int:KIF13B
InteractionPHLDB2 interactions

SIPA1L1 YWHAQ BTRC SFN

4.34e-04143504int:PHLDB2
InteractionCDKN1B interactions

MAPK15 ABCF3 YWHAQ TAGLN

4.46e-04144504int:CDKN1B
InteractionZNF638 interactions

JPH4 SIPA1L1 SRPK2 YWHAQ SFN

4.62e-04261505int:ZNF638
InteractionKCNK3 interactions

YWHAQ SFN

4.62e-0413502int:KCNK3
InteractionAMER1 interactions

ARL13B SRPK2 BTRC

4.67e-0461503int:AMER1
InteractionMAPKAP1 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

4.70e-04146504int:MAPKAP1
InteractionERBIN interactions

RHBDF2 ARL13B YWHAQ BTRC SFN

4.95e-04265505int:ERBIN
InteractionCDC25A interactions

RBBP7 YWHAQ BTRC SFN

5.34e-04151504int:CDC25A
InteractionGCKR interactions

YWHAQ SFN

5.39e-0414502int:GCKR
InteractionCGN interactions

SIPA1L1 YWHAQ SH3RF3 SFN

5.47e-04152504int:CGN
InteractionGSE1 interactions

RBBP4 RBBP7 SRPK2 LHX3

5.75e-04154504int:GSE1
InteractionPHF19 interactions

RBBP4 RBBP7 BTRC

5.89e-0466503int:PHF19
InteractionBAZ1A interactions

RBBP4 RBBP7 SRPK2 YWHAQ

6.03e-04156504int:BAZ1A
InteractionCDC25C interactions

SIPA1L1 YWHAQ SH3RF3 SFN

6.03e-04156504int:CDC25C
InteractionFBXW8 interactions

RBBP4 NLRP1 YWHAQ BTRC

6.18e-04157504int:FBXW8
InteractionRASAL2 interactions

SIPA1L1 ARL13B YWHAQ SFN

6.33e-04158504int:RASAL2
InteractionMTMR4 interactions

ABCF3 YWHAQ LANCL2 SFN

6.33e-04158504int:MTMR4
InteractionH3C2 interactions

MMS22L RBBP4 RBBP7

6.43e-0468503int:H3C2
InteractionFAM53C interactions

SIPA1L1 YWHAQ SFN

6.43e-0468503int:FAM53C
InteractionHDAC5 interactions

PSMD6 RBBP4 RBBP7 YWHAQ BTRC SFN

6.71e-04432506int:HDAC5
InteractionZBTB21 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

6.79e-04161504int:ZBTB21
InteractionSAMSN1 interactions

YWHAQ SFN

7.08e-0416502int:SAMSN1
InteractionBTF3 interactions

PRSS3P2 SMG1 RBBP4 RBBP7 SIPA1L1 SAR1B SRPK2 YWHAQ

7.23e-04799508int:BTF3
InteractionIFT81 interactions

JPH4 ARL13B NLRP1

7.29e-0471503int:IFT81
InteractionCCDC71 interactions

RBBP4 RBBP7 PPID

7.60e-0472503int:CCDC71
InteractionLPIN3 interactions

SIPA1L1 YWHAQ SH3RF3

7.91e-0473503int:LPIN3
InteractionMAP3K2 interactions

YWHAQ BTRC SFN

7.91e-0473503int:MAP3K2
InteractionH3C7 interactions

MMS22L RBBP4 RBBP7

7.91e-0473503int:H3C7
InteractionZNF395 interactions

YWHAQ BTRC

8.01e-0417502int:ZNF395
InteractionTCF3 interactions

RBBP4 RBBP7 YWHAQ LANCL2 SFN

8.03e-04295505int:TCF3
InteractionARHGAP19 interactions

RBBP7 YWHAQ SFN

8.23e-0474503int:ARHGAP19
InteractionPARD3 interactions

SIPA1L1 ARL13B SLC6A15 YWHAQ SFN

8.40e-04298505int:PARD3
InteractionEPB41L2 interactions

RHBDF2 ARL13B SRPK2 YWHAQ SFN

8.53e-04299505int:EPB41L2
InteractionTTN interactions

JPH1 KY SAR1B SRPK2 YWHAQ

8.53e-04299505int:TTN
InteractionPWWP2B interactions

RBBP4 RBBP7

9.00e-0418502int:PWWP2B
InteractionFAM53B interactions

YWHAQ SFN

9.00e-0418502int:FAM53B
InteractionSIPA1L1 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

9.07e-04174504int:SIPA1L1
InteractionSHCBP1 interactions

RBBP4 YWHAQ SFN

9.24e-0477503int:SHCBP1
InteractionARGLU1 interactions

RBBP7 SRPK2 BTRC JPH3

9.46e-04176504int:ARGLU1
InteractionSHROOM3 interactions

SAR1B YWHAQ SFN

9.59e-0478503int:SHROOM3
InteractionPTPN14 interactions

JPH4 SIPA1L1 YWHAQ SFN

9.67e-04177504int:PTPN14
InteractionGIGYF1 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

9.67e-04177504int:GIGYF1
InteractionLARP1 interactions

RHBDF2 SIPA1L1 FGF13 YWHAQ BTRC SFN

9.83e-04465506int:LARP1
InteractionFAM163A interactions

YWHAQ SFN

1.00e-0319502int:FAM163A
InteractionACACA interactions

PSMD6 RBBP4 RBBP7 SAR1B YWHAQ BTRC

1.00e-03467506int:ACACA
InteractionCBARP interactions

TMC6 YWHAQ SFN

1.03e-0380503int:CBARP
InteractionPDE3A interactions

JPH1 YWHAQ BTRC

1.03e-0380503int:PDE3A
InteractionCBY1 interactions

SIPA1L1 YWHAQ SH3RF3 SFN

1.07e-03182504int:CBY1
GeneFamilyLysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2

RBBP4 RBBP7

5.43e-0563521347
GeneFamily14-3-3 phospho-serine/phospho-threonine binding proteins

YWHAQ SFN

7.60e-0573521053
GeneFamilyHistone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex

RBBP4 RBBP7

1.30e-0493521306
GeneFamilyPHD finger proteins|NuRD complex

RBBP4 RBBP7

2.37e-04123521305
GeneFamilyHistone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex

RBBP4 RBBP7

2.37e-04123521243
GeneFamilyWD repeat domain containing

RBBP4 RBBP7 EML2 BTRC

1.58e-03262354362
GeneFamilyRing finger proteins|Tripartite motif containing|ARF GTPase family

SAR1B ARL13B

1.63e-0331352357
GeneFamilyCytochrome P450 family 2

CYP2B6 CYP2C19

2.08e-03353521001
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

LCNL1 CLEC4G YWHAQ TAGLN LANCL2

5.51e-0714250561eefa32926a057e53747633bf4a81f09ea721c5
Drug4-bromo-2-chlorophenol

CYP2B6 CYP2C19

1.42e-053502ctd:C075205
Drugnorflurazone

CYP2B6 CYP2C19

1.42e-053502ctd:C008677
Drug2,2-dichloro-1,1,1-trifluoroethane

CYP2B6 CYP2C19

1.42e-053502ctd:C067411
DrugN-desmethylclobazam

CYP2B6 CYP2C19

1.42e-053502ctd:C024581
Drugmethiocarb sulfoxide

CYP2B6 CYP2C19

2.83e-054502ctd:C097911
Drug7-ethoxy-4-trifluoromethylcoumarin

CYP2B6 CYP2C19

2.83e-054502ctd:C056033
Drug4-(methylsulfinyl)phenol

CYP2B6 CYP2C19

2.83e-054502ctd:C044390
Drug5-methoxy-N,N-diisopropyltryptamine

CYP2B6 CYP2C19

2.83e-054502ctd:C033696
DrugN-isopropyl-1,2-diphenylethylamine

CYP2B6 CYP2C19

2.83e-054502ctd:C000598691
DrugN,N-diallyl-5-methoxytryptamine

CYP2B6 CYP2C19

4.71e-055502ctd:C578955
Druglephetamine

CYP2B6 CYP2C19

4.71e-055502ctd:C011896
Drug2-oxo-clopidogrel

CYP2B6 CYP2C19

4.71e-055502ctd:C540904
Drugamitriptyline N-oxide

CYP2B6 CYP2C19

4.71e-055502ctd:C006566
Drugimipramine N-oxide

CYP2B6 CYP2C19

4.71e-055502ctd:C002921
Drugbenfuracarb

CYP2B6 CYP2C19

4.71e-055502ctd:C096128
DrugN-ethyl-1,2-diphenylethylamine

CYP2B6 CYP2C19

4.71e-055502ctd:C000598690
Drug3-bromomethcathinone

CYP2B6 CYP2C19

7.05e-056502ctd:C571631
Drug3,5-xylenol

CYP2B6 CYP2C19

7.05e-056502ctd:C016834
Drug4',5-dihydroxydiclofenac

CYP2B6 CYP2C19

7.05e-056502CID003052567
Drug4-en-VPA

CYP2B6 NLRP1

7.05e-056502CID000104896
Drugavasimibe

CYP2B6 CYP2C19

7.05e-056502ctd:C423185
DrugN,N-diisopropyltryptamine

CYP2B6 CYP2C19

7.05e-056502ctd:C033695
Drugmepirodipine

CYP2B6 CYP2C19

7.05e-056502ctd:C050699
Drug3'-hydroxydiclofenac

CYP2B6 CYP2C19

7.05e-056502CID000112230
DrugOxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A

CYP2B6 EML2 NLRP1 SLC6A15 BTRC

7.29e-051985054530_UP
Drugindopan

CYP2B6 CYP2C19

9.86e-057502ctd:C015293
Drug5-fluorotryptamine

CYP2B6 CYP2C19

9.86e-057502ctd:C034536
Drugtrichloroacetyl chloride

CYP2B6 CYP2C19

9.86e-057502CID000006420
Drug5-hydroxydiclofenac

CYP2B6 CYP2C19

9.86e-057502ctd:C117715
Drug5-fluoro-alpha-methyltryptamine

CYP2B6 CYP2C19

1.31e-048502ctd:C051101
Drug5-methyltryptamine

CYP2B6 CYP2C19

1.31e-048502ctd:C027552
Drug5-bromotryptamine

CYP2B6 CYP2C19

1.31e-048502ctd:C040997
Drugclobazam

CYP2B6 CYP2C19

1.31e-048502ctd:C012255
Druggermacrone

CYP2B6 CYP2C19

1.31e-048502ctd:C048393
Drug7-methyltryptamine

CYP2B6 CYP2C19

1.31e-048502ctd:C036696
Drugteucrin A

CYP2B6 NLRP1

1.68e-049502CID000159529
Drug4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide

CYP2B6 CYP2C19

1.68e-049502ctd:C545880
Drugtrifluoroacetyl chloride

CYP2B6 CYP2C19

1.68e-049502CID000061106
DrugAC1L8U1Y

CYP2B6 CYP2C19

1.68e-049502CID000408120
Drug5-chlorotryptamine

CYP2B6 CYP2C19

1.68e-049502ctd:C529169
Drug2-nitroanisole

CYP2B6 CYP2C19

1.68e-049502ctd:C005328
Drug5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid

CYP2B6 CYP2C19

1.68e-049502ctd:C000588958
Drug7-hydroxy-4-trifluoromethylcoumarin

CYP2B6 CYP2C19

1.68e-049502ctd:C084236
DrugTryptamines

CYP2B6 CYP2C19

1.68e-049502ctd:D014363
DrugN-desmethylclobazam

CYP2B6 CYP2C19

1.68e-049502CID000089657
DrugIfosfamide

CYP2B6 CYP2C19 SPSB1 DGKA SFN

2.09e-04248505ctd:D007069
DrugCelsior

CYP2B6 CYP2C19

2.10e-0410502ctd:C088453
DrugMephenytoin

CYP2B6 CYP2C19

2.10e-0410502ctd:D008617
Drugsulconazole

CYP2B6 CYP2C19

2.10e-0410502CID000005318
Drug3-hydroxyflunitrazepam

CYP2B6 CYP2C19

2.10e-0410502CID000128908
DrugAHMA

CYP2B6 CYP2C19

2.10e-0410502CID000216240
DrugS)-3-phenylpiperidine

CYP2B6 CYP2C19

2.10e-0410502CID000101021
Drug2-hydroxycarbamazepine

CYP2B6 CYP2C19

2.10e-0410502CID000129274
Drug3-methylbutoxy

CYP2B6 CYP2C19

2.10e-0410502CID000012988
Drugnorketobemidone

CYP2B6 CYP2C19

2.10e-0410502CID000161154
DrugAC1L2U5I

NLRP1 JPH3

2.57e-0411502CID000128642
Drugtrans-1,2-dihydro-1,2-naphthalenediol

CYP2B6 CYP2C19

2.57e-0411502ctd:C507866
DrugTicalopride

CYP2B6 CYP2C19

2.57e-0411502CID000216236
DrugArachidonic Acids

CYP2B6 CYP2C19

2.57e-0411502ctd:D001095
DrugRacemic mixture

CYP2B6 CYP2C19 NLRP1

2.82e-0458503CID000365464
DrugAMOX

CYP2C19 NLRP1

3.08e-0412502CID000026304
Drug5-hydroxydiclofenac

CYP2B6 CYP2C19

3.08e-0412502CID003052566
Drugcarveol

CYP2B6 CYP2C19

3.08e-0412502CID000007438
Drug2-phenylethylglucosinolate

CYP2B6 NLRP1

3.08e-0412502CID000656554
Drugsibutramine

CYP2B6 CYP2C19

3.08e-0412502ctd:C058254
Drugfullerene C60

JPH1 PSMD6 KY ABCF3 RHBDF2 SPSB1 CCDC187 OSBP2 LHX3 MMP11 SH3RF3

3.32e-0414985011ctd:C069837
Drugdibromopropanol

PAM NLRP1

3.63e-0413502CID000007281
Drug7-hydroxyquinoline

CYP2B6 CYP2C19

3.63e-0413502CID000011378
Diseasecardiomyopathy (implicated_via_orthology)

JPH1 JPH4 JPH3

2.27e-0471493DOID:0050700 (implicated_via_orthology)
Diseaseintellectual disability (implicated_via_orthology)

FGF13 YWHAQ SFN

2.67e-0475493DOID:1059 (implicated_via_orthology)
Diseasesunburn

MMS22L SLC6A17 SRPK2

5.52e-0496493EFO_0003958
Diseaseneurotic disorder

TMPRSS9 MMS22L SIPA1L1

6.40e-04101493EFO_0004257
Diseasewaist-hip ratio

KY MMS22L SPSB1 PAM SLC6A15 SRPK2 FGF13 YWHAQ

8.59e-041226498EFO_0004343
Diseasetuberculosis (is_implicated_in)

CYP2B6 CYP2C19

9.93e-0428492DOID:399 (is_implicated_in)
Diseaseage at first birth measurement

SIPA1L1 SLC6A15 PPID

1.05e-03120493EFO_0009101
DiseaseKeloid

TAGLN SFN

1.55e-0335492C0022548

Protein segments in the cluster

PeptideGeneStartEntry
VAYKNVVGGRRSAWR

YWHAQ

46

P27348
YGVIFANGNRWKVLR

CYP2B6

111

P20813
LVGVYAWRKGQALVR

CCDC187

281

A0A096LP49
WVNEQRYGGISIGGK

ABCA4

1551

P78363
VAYKNVVGGQRAAWR

SFN

46

P31947
GLAERRGWGQYLFKN

BTRC

241

Q9Y297
ADVNLAWGRRYGLVG

ABCF3

196

Q9NUQ8
LGKVVSGYRVRNGQW

PAM

241

P19021
SGYRVRNGQWTLIGR

PAM

246

P19021
DLGGGIRIRGIWKNY

ARL13B

71

Q3SXY8
RDWKQYKQGFGSIRG

ANGPTL7

186

O43827
KGGLRNQWLQLYGGR

LCNL1

91

Q6ZST4
NQWLQLYGGRAAGRR

LCNL1

96

Q6ZST4
RRQLGQGAYGIVWKA

MAPK15

16

Q8TD08
QKWGLGRNIAQREAY

MMS22L

1206

Q6ZRQ5
GFQGVGNGVRRWQKL

KY

46

Q8NBH2
YQGHWQQGKREGLGV

JPH4

61

Q96JJ6
GQWQAGKRHGYGVRQ

JPH4

131

Q96JJ6
QGYWAQGKRHGLGVE

JPH1

61

Q9HDC5
SDVIWQRGLLRKGYG

LANCL2

351

Q9NS86
DADGRIYIRNWQGGI

PDPR

286

Q8NCN5
IYIRNWQGGILSGGF

PDPR

291

Q8NCN5
QVKEAWGRGQLYGDR

NLRP1

346

Q9C000
LRWGGGYEGQNLAKI

DGKA

471

P23743
KKDAGRQRWGQYFRN

LHX3

216

Q9UBR4
LKGYQRRWFVLGNGL

OSBP2

196

Q969R2
LRLRGHQKEGYGLSW

RBBP4

171

Q09028
RLRGHQKEGYGLSWN

RBBP7

171

Q16576
ANRGFGIVFSNGKRW

CYP2C19

106

P33261
SRVGHIYRLEGWQGN

GALNT7

436

Q86SF2
RQQQSGRGWYLGLNK

FGF13

161

Q92913
YVWGKGGNRITQAVL

EML2

276

O95834
GGDWDRRNRLKVYQG

PSMD6

171

Q15008
RRAGSQKLWLAVRYG

PHKB

771

Q93100
FKAGFVWRLRGGQLQ

MMP11

311

P24347
VGQRIRRGSIGVWNY

SLC6A15

121

Q9H2J7
QGIVSWGYGCAQKRR

PRSS3P2

211

Q8NHM4
NTKALYRRAQGWQGL

PPID

306

Q08752
AYRWGRKVVDNASQG

SMG1

1626

Q96Q15
GYAWQAGLRQGSRLV

SIPA1L1

981

O43166
DRGRLGFQVWLKNGV

TAGLN

46

Q01995
IWNAGKQGRRLYRSL

B3GNTL1

266

Q67FW5
RAVRHLGKVQGYQWV

CLEC4G

226

Q6UXB4
YLQRQGRGAVWGSVI

TTLL8

481

A6PVC2
GWDLGRNRLYHDGKN

SPSB1

141

Q96BD6
REDGWYKGTLQRNGR

SH3RF3

856

Q8TEJ3
LFNGRYHVIRKLGWG

SRPK2

76

P78362
GVYTRVAAVRGWIGQ

TMPRSS9

1041

Q7Z410
YIGNKVRRQRMWGGG

POLR3B

286

Q9NW08
GQRIRRGSIGVWHYI

SLC6A17

121

Q9H1V8
YHWLGRRVGVLQGQC

TMC6

526

Q7Z403
LGGHVQARRVWKNYL

SAR1B

76

Q9Y6B6
KRHYGLGVVGNWLNR

RHBDF2

366

Q6PJF5
RGVEKHIRAQGWNYG

TGM6

166

O95932
YQGTWAQGKRHGIGL

JPH3

61

Q8WXH2